| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 64.5K | Jun 19, 2024 | Direct | ||
| LEAP THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 25K | Oct 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LPTX | LEAP THERAPEUTICS, INC. | Oct 2, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
| ANTX | AN2 Therapeutics, Inc. | Jun 19, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| LPTX | LEAP THERAPEUTICS, INC. | Jan 29, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Director |
| LPTX | LEAP THERAPEUTICS, INC. | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Director |
| ANTX | AN2 Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| LPTX | LEAP THERAPEUTICS, INC. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| LPTX | LEAP THERAPEUTICS, INC. | Jan 17, 2023 | 0 | $0 | 3 | Jan 25, 2023 | Director |
| ANTX | AN2 Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
| ANTX | AN2 Therapeutics, Inc. | Mar 24, 2022 | 0 | $0 | 3 | Mar 24, 2022 | Director |